Biotech Pre-Market Movers: SLXN, SMMT Surge; NIVF, QURE Slide
Article
Credit: Gayathry Prakash
Biotech stocks are seeing significant pre-market activity this Tuesday driven largely by company-specific developments. Silexion Therapeutics surged on positive preclinical data, while Summit Therapeutics jumped following a $2 billion equity investment from AstraZeneca.